|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 9/107 | (2006.01) |
| A61K 9/48 | (2006.01) | ||
| A61K 31/4709 | (2006.01) | ||
| A61P 7/10 | (2006.01) |
| (11) | Number of the document | 4203919 |
| (13) | Kind of document | T |
| (96) | European patent application number | 22760986.4 |
| Date of filing the European patent application | 2022-08-05 | |
| (97) | Date of publication of the European application | 2023-07-05 |
| (45) | Date of publication and mention of the grant of the patent | 2024-01-31 |
| (46) | Date of publication of the claims translation | 2024-05-10 |
| (86) | Number | PCT/EP2022/072049 |
| Date | 2022-08-05 |
| (87) | Number | WO 2023/012322 |
| Date | 2023-02-09 |
| (30) | Number | Date | Country code |
| 21189990 | 2021-08-05 | EP |
| (72) |
GIBSON, Christoph , CH
|
| (73) |
Pharvaris GmbH ,
Grafenauweg 8, 6300 Zug,
CH
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Kompozicijos lipidų pagrindu, skirtos bradikinino B2 receptoriaus antagonistų įvedimui |
| LIPID-BASED COMPOSITION FOR ORAL ADMINISTRATION OF BRADYKININ B2-RECEPTOR ANTAGONISTS |
| Payment date | Validity (years) | Amount | |
| 2025-07-22 | 4 | 92.00 EUR |
| 2026-08-05 |